世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

北米セルライト治療市場 2023-2030


NORTH AMERICA CELLULITE TREATMENT MARKET 2023-2030

市場の展望 Triton Market Researchのレポートによると、北米のセルライト治療市場は、2023年から2030年の予測期間において、年平均成長率9.58%で推移するとされています。同地域では、カナダと米国が計られてい... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 言語
Triton Market Research
トリトンマーケットリサーチ 		2023年5月2日 US$1,500
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		116 英語

　

サマリー

市場の展望
Triton Market Researchのレポートによると、北米のセルライト治療市場は、2023年から2030年の予測期間において、年平均成長率9.58%で推移するとされています。同地域では、カナダと米国が計られています。
カナダでは、肥満の有病率の高さが市場成長の原動力となることが予想されます。推定によると、不健康なライフスタイルの選択により、肥満と診断される人の数は増加すると予想されます。このため、外見を美しくするための美容整形に対する需要がさらに高まると考えられます。さらに、老年人口の増加も、セルライト除去などの美容施術の需要を高めています。この点で、非侵襲的かつ低侵襲的な治療法は、セルライト治療市場の拡大を大きく後押ししています。
同様に、肥満率の高さから、米国ではさまざまな治療法を選択せざるを得ない状況になっています。低侵襲な施術が可能なため、セルライト治療を選択する患者数が大幅に増加しました。したがって、美意識の高まりと先進的な治療法が、米国におけるセルライト治療市場の全体的な範囲と成長を拡大させているのです。

競争展望
セルライト治療市場の既存企業は、AbbVie Inc、Bausch Health Companies Inc、Johnson & Johnson、Galderma SA、Endo International Plcで構成されています。


ページTOPに戻る


目次

TABLE OF CONTENTS
1. NORTH AMERICA CELLULITE TREATMENT MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. PARENT MARKET ANALYSIS
2.2. IMPACT ANALYSIS ON THE CELLULITE TREATMENT MARKET
2.2.1. COVID-19 IMPACT ON THE CELLULITE TREATMENT MARKET
2.2.2. UKRAINE-RUSSIA WAR IMPACT ON THE CELLULITE TREATMENT MARKET
2.3. PORTER’S FIVE FORCES ANALYSIS
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTES
2.3.3. BARGAINING POWER OF BUYERS
2.3.4. BARGAINING POWER OF SUPPLIERS
2.3.5. THREAT OF COMPETITIVE RIVALRY
2.4. MARKET MATURITY ANALYSIS
2.5. INDUSTRY COMPONENTS
2.5.1. RESEARCH AND DEVELOPMENT
2.5.2. MANUFACTURING OF PRODUCT
2.5.3. DISTRIBUTION
2.5.4. POST-SALES MONITORING
2.6. REGULATORY FRAMEWORK
2.7. KEY BUYING IMPACT ANALYSIS
2.7.1. PRICE
2.7.2. BRAND NAME
2.7.3. USABILITY
2.8. KEY MARKET STRATEGIES
2.8.1. COLLABORATIONS
2.8.2. PRODUCT LAUNCHES
2.8.3. MERGERS & ACQUISITIONS
2.8.4. BUSINESS DIVESTITURES & EXPANSIONS
2.9. MARKET DRIVERS
2.9.1. GROWING PREVALENCE OF OBESITY
2.9.2. RAPIDLY GROWING MEDICAL TOURISM SECTOR
2.9.3. RISING DEMAND FOR AESTHETIC PROCEDURES
2.10. MARKET CHALLENGES
2.10.1. LACK OF KNOWLEDGE REGARDING CELLULITE TREATMENT
2.10.2. HIGH PRICE OF ADVANCED CELLULITE TREATMENT
2.10.3. RISKS ASSOCIATED POST-TREATMENT
2.11. MARKET OPPORTUNITIES
2.11.1. RISING BEAUTY CONSCIOUSNESS
2.11.2. INCREASING TREND OF ANTI-CELLULITE MASSAGE
2.11.3. GROWING DEMAND FOR MINIMALLY INVASIVE AND NON-INVASIVE PROCEDURES
2.11.4. RISING POPULARITY OF RADIOFREQUENCY THERAPY FOR CELLULITE TREATMENT
2.11.5. ADVANCEMENTS IN TECHNOLOGIES AND NEW PRODUCT LAUNCHES
2.12. ANALYST PERSPECTIVE
3. NORTH AMERICA CELLULITE TREATMENT MARKET – BY CELLULITE TYPE
3.1. SOFT CELLULITE
3.2. HARD CELLULITE
3.3. EDEMATOUS CELLULITE
4. NORTH AMERICA CELLULITE TREATMENT MARKET – BY PROCEDURE TYPE
4.1. NON-INVASIVE
4.2. MINIMALLY INVASIVE
4.3. TOPICAL
5. NORTH AMERICA CELLULITE TREATMENT MARKET – BY END-USER
5.1. HOSPITALS
5.2. CLINICS AND BEAUTY CENTERS
5.3. OTHER END-USERS
6. NORTH AMERICA CELLULITE TREATMENT MARKET – BY COUNTRY OUTLOOK
6.1. COUNTRY ANALYSIS
6.1.1. UNITED STATES
6.1.1.1. UNITED STATES CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.1.2. CANADA
6.1.2.1. CANADA CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
7. COMPETITIVE LANDSCAPE
7.1. JOHNSON & JOHNSON
7.1.1. OVERVIEW
7.1.2. PRODUCT PORTFOLIO
7.1.3. KEY STRENGTHS
7.1.4. KEY CHALLENGES
7.2. ABBVIE INC
7.2.1. OVERVIEW
7.2.2. PRODUCT PORTFOLIO
7.2.3. KEY STRENGTHS
7.2.4. KEY CHALLENGES
7.3. BAUSCH HEALTH COMPANIES INC
7.3.1. OVERVIEW
7.3.2. PRODUCT PORTFOLIO
7.3.3. KEY STRENGTHS
7.3.4. KEY CHALLENGES
7.4. CUTERA INC
7.4.1. OVERVIEW
7.4.2. PRODUCT PORTFOLIO
7.4.3. KEY STRENGTHS
7.4.4. KEY CHALLENGES
7.5. INCELER MEDIKAL
7.5.1. OVERVIEW
7.5.2. PRODUCT PORTFOLIO
7.5.3. KEY STRENGTHS
7.5.4. KEY CHALLENGES
7.6. ZIMMER MEDIZINSYSTEME GMBH
7.6.1. OVERVIEW
7.6.2. PRODUCT PORTFOLIO
7.6.3. KEY STRENGTHS
7.6.4. KEY CHALLENGES
7.7. GALDERMA SA
7.7.1. OVERVIEW
7.7.2. PRODUCT PORTFOLIO
7.7.3. KEY STRENGTHS
7.7.4. KEY CHALLENGES
7.8. SIENTRA INC
7.8.1. OVERVIEW
7.8.2. PRODUCT PORTFOLIO
7.8.3. KEY STRENGTHS
7.8.4. KEY CHALLENGES
7.9. ENDO INTERNATIONAL PLC
7.9.1. OVERVIEW
7.9.2. PRODUCT PORTFOLIO
7.9.3. KEY STRENGTHS
7.9.4. KEY CHALLENGES
7.10. CANDELA MEDICAL CORPORATION
7.10.1. OVERVIEW
7.10.2. PRODUCT PORTFOLIO
7.10.3. KEY STRENGTHS
7.10.4. KEY CHALLENGES
8. RESEARCH METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE & DELIVERABLES
8.1.1. OBJECTIVES OF STUDY
8.1.2. SCOPE OF STUDY
8.2. SOURCES OF DATA
8.2.1. PRIMARY DATA SOURCES
8.2.2. SECONDARY DATA SOURCES
8.3. RESEARCH METHODOLOGY
8.3.1. EVALUATION OF THE PROPOSED MARKET
8.3.2. IDENTIFICATION OF DATA SOURCES
8.3.3. ASSESSMENT OF MARKET DETERMINANTS
8.3.4. DATA COLLECTION
8.3.5. DATA VALIDATION & ANALYSIS


TABLE LIST
TABLE 1: NORTH AMERICA CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 2: REGULATORY FRAMEWORK
TABLE 3: LIST OF COLLABORATIONS
TABLE 4: LIST OF PRODUCT LAUNCHES
TABLE 5: LIST OF MERGERS & ACQUISITIONS
TABLE 6: LIST OF BUSINESS DIVESTITURES & EXPANSIONS
TABLE 7: NORTH AMERICA CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2023-2030 (IN $ MILLION)
TABLE 8: NORTH AMERICA CELLULITE TREATMENT MARKET, BY PROCEDURE TYPE, 2023-2030 (IN $ MILLION)
TABLE 9: NORTH AMERICA CELLULITE TREATMENT MARKET, BY END-USER, 2023-2030 (IN $ MILLION)
TABLE 10: NORTH AMERICA CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)

FIGURE LIST
FIGURE 1: MARKET MATURITY ANALYSIS
FIGURE 2: INDUSTRY COMPONENTS
FIGURE 3: KEY BUYING IMPACT ANALYSIS
FIGURE 4: NORTH AMERICA CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2022 & 2030 (IN %)
FIGURE 5: NORTH AMERICA CELLULITE TREATMENT MARKET, BY SOFT CELLULITE, 2023-2030 (IN $ MILLION)
FIGURE 6: NORTH AMERICA CELLULITE TREATMENT MARKET, BY HARD CELLULITE, 2023-2030 (IN $ MILLION)
FIGURE 7: NORTH AMERICA CELLULITE TREATMENT MARKET, BY PROCEDURE TYPE, 2022 & 2030 (IN %)
FIGURE 8: NORTH AMERICA CELLULITE TREATMENT MARKET, BY NON-INVASIVE, 2023-2030 (IN $ MILLION)
FIGURE 9: NORTH AMERICA CELLULITE TREATMENT MARKET, BY MINIMALLY INVASIVE, 2023-2030 (IN $ MILLION)
FIGURE 10: NORTH AMERICA CELLULITE TREATMENT MARKET, BY TOPICAL, 2023-2030 (IN $ MILLION)
FIGURE 11: NORTH AMERICA CELLULITE TREATMENT MARKET, BY END-USER, 2022 & 2030 (IN %)
FIGURE 12: NORTH AMERICA CELLULITE TREATMENT MARKET, BY HOSPITALS, 2023-2030 (IN $ MILLION)
FIGURE 13: NORTH AMERICA CELLULITE TREATMENT MARKET, BY CLINICS AND BEAUTY CENTERS, 2023-2030 (IN $ MILLION)
FIGURE 14: NORTH AMERICA CELLULITE TREATMENT MARKET, BY OTHER END-USERS, 2023-2030 (IN $ MILLION)
FIGURE 15: NORTH AMERICA CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2022 & 2030 (IN %)
FIGURE 16: UNITED STATES CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 17: CANADA CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)

ページTOPに戻る



図表リスト

TABLE LIST
TABLE 1: NORTH AMERICA CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 2: REGULATORY FRAMEWORK
TABLE 3: LIST OF COLLABORATIONS
TABLE 4: LIST OF PRODUCT LAUNCHES
TABLE 5: LIST OF MERGERS & ACQUISITIONS
TABLE 6: LIST OF BUSINESS DIVESTITURES & EXPANSIONS
TABLE 7: NORTH AMERICA CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2023-2030 (IN $ MILLION)
TABLE 8: NORTH AMERICA CELLULITE TREATMENT MARKET, BY PROCEDURE TYPE, 2023-2030 (IN $ MILLION)
TABLE 9: NORTH AMERICA CELLULITE TREATMENT MARKET, BY END-USER, 2023-2030 (IN $ MILLION)
TABLE 10: NORTH AMERICA CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)

　

ページTOPに戻る


　

Summary

MARKET OUTLOOK
Triton Market Research’s report reckons that the cellulite treatment market in North America is set to advance with a compound annual growth rate of 9.58% over the forecasting years 2023-2030. Canada and the United States are gauged in the region.
The high prevalence of obesity is expected to drive the market’s growth in Canada. As per estimates, the number of people diagnosed with obesity is expected to rise owing to unhealthy lifestyle choices. This will further elevate the demand for cosmetic procedures to enhance appearance. Moreover, the increase in the geriatric population has also surged the demand for aesthetic treatments like cellulite reduction. In this regard, non-invasive and minimally invasive treatments have significantly backed the expansion of the cellulite treatment market.
Likewise, the high obesity rates have compelled people to opt for various treatments in the US. The availability of minimally invasive procedures has significantly increased the number of patients opting for cellulite treatments. Hence, the growing beauty consciousness and advanced treatments widen the overall scope and growth of the cellulite treatment market across the United States.

COMPETITIVE OUTLOOK
The established companies in the cellulite treatment market consist of AbbVie Inc, Bausch Health Companies Inc, Johnson & Johnson, Galderma SA, and Endo International Plc.



ページTOPに戻る


Table of Contents

TABLE OF CONTENTS
1. NORTH AMERICA CELLULITE TREATMENT MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. PARENT MARKET ANALYSIS
2.2. IMPACT ANALYSIS ON THE CELLULITE TREATMENT MARKET
2.2.1. COVID-19 IMPACT ON THE CELLULITE TREATMENT MARKET
2.2.2. UKRAINE-RUSSIA WAR IMPACT ON THE CELLULITE TREATMENT MARKET
2.3. PORTER’S FIVE FORCES ANALYSIS
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTES
2.3.3. BARGAINING POWER OF BUYERS
2.3.4. BARGAINING POWER OF SUPPLIERS
2.3.5. THREAT OF COMPETITIVE RIVALRY
2.4. MARKET MATURITY ANALYSIS
2.5. INDUSTRY COMPONENTS
2.5.1. RESEARCH AND DEVELOPMENT
2.5.2. MANUFACTURING OF PRODUCT
2.5.3. DISTRIBUTION
2.5.4. POST-SALES MONITORING
2.6. REGULATORY FRAMEWORK
2.7. KEY BUYING IMPACT ANALYSIS
2.7.1. PRICE
2.7.2. BRAND NAME
2.7.3. USABILITY
2.8. KEY MARKET STRATEGIES
2.8.1. COLLABORATIONS
2.8.2. PRODUCT LAUNCHES
2.8.3. MERGERS & ACQUISITIONS
2.8.4. BUSINESS DIVESTITURES & EXPANSIONS
2.9. MARKET DRIVERS
2.9.1. GROWING PREVALENCE OF OBESITY
2.9.2. RAPIDLY GROWING MEDICAL TOURISM SECTOR
2.9.3. RISING DEMAND FOR AESTHETIC PROCEDURES
2.10. MARKET CHALLENGES
2.10.1. LACK OF KNOWLEDGE REGARDING CELLULITE TREATMENT
2.10.2. HIGH PRICE OF ADVANCED CELLULITE TREATMENT
2.10.3. RISKS ASSOCIATED POST-TREATMENT
2.11. MARKET OPPORTUNITIES
2.11.1. RISING BEAUTY CONSCIOUSNESS
2.11.2. INCREASING TREND OF ANTI-CELLULITE MASSAGE
2.11.3. GROWING DEMAND FOR MINIMALLY INVASIVE AND NON-INVASIVE PROCEDURES
2.11.4. RISING POPULARITY OF RADIOFREQUENCY THERAPY FOR CELLULITE TREATMENT
2.11.5. ADVANCEMENTS IN TECHNOLOGIES AND NEW PRODUCT LAUNCHES
2.12. ANALYST PERSPECTIVE
3. NORTH AMERICA CELLULITE TREATMENT MARKET – BY CELLULITE TYPE
3.1. SOFT CELLULITE
3.2. HARD CELLULITE
3.3. EDEMATOUS CELLULITE
4. NORTH AMERICA CELLULITE TREATMENT MARKET – BY PROCEDURE TYPE
4.1. NON-INVASIVE
4.2. MINIMALLY INVASIVE
4.3. TOPICAL
5. NORTH AMERICA CELLULITE TREATMENT MARKET – BY END-USER
5.1. HOSPITALS
5.2. CLINICS AND BEAUTY CENTERS
5.3. OTHER END-USERS
6. NORTH AMERICA CELLULITE TREATMENT MARKET – BY COUNTRY OUTLOOK
6.1. COUNTRY ANALYSIS
6.1.1. UNITED STATES
6.1.1.1. UNITED STATES CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
6.1.2. CANADA
6.1.2.1. CANADA CELLULITE TREATMENT MARKET FORECAST & PROSPECTS
7. COMPETITIVE LANDSCAPE
7.1. JOHNSON & JOHNSON
7.1.1. OVERVIEW
7.1.2. PRODUCT PORTFOLIO
7.1.3. KEY STRENGTHS
7.1.4. KEY CHALLENGES
7.2. ABBVIE INC
7.2.1. OVERVIEW
7.2.2. PRODUCT PORTFOLIO
7.2.3. KEY STRENGTHS
7.2.4. KEY CHALLENGES
7.3. BAUSCH HEALTH COMPANIES INC
7.3.1. OVERVIEW
7.3.2. PRODUCT PORTFOLIO
7.3.3. KEY STRENGTHS
7.3.4. KEY CHALLENGES
7.4. CUTERA INC
7.4.1. OVERVIEW
7.4.2. PRODUCT PORTFOLIO
7.4.3. KEY STRENGTHS
7.4.4. KEY CHALLENGES
7.5. INCELER MEDIKAL
7.5.1. OVERVIEW
7.5.2. PRODUCT PORTFOLIO
7.5.3. KEY STRENGTHS
7.5.4. KEY CHALLENGES
7.6. ZIMMER MEDIZINSYSTEME GMBH
7.6.1. OVERVIEW
7.6.2. PRODUCT PORTFOLIO
7.6.3. KEY STRENGTHS
7.6.4. KEY CHALLENGES
7.7. GALDERMA SA
7.7.1. OVERVIEW
7.7.2. PRODUCT PORTFOLIO
7.7.3. KEY STRENGTHS
7.7.4. KEY CHALLENGES
7.8. SIENTRA INC
7.8.1. OVERVIEW
7.8.2. PRODUCT PORTFOLIO
7.8.3. KEY STRENGTHS
7.8.4. KEY CHALLENGES
7.9. ENDO INTERNATIONAL PLC
7.9.1. OVERVIEW
7.9.2. PRODUCT PORTFOLIO
7.9.3. KEY STRENGTHS
7.9.4. KEY CHALLENGES
7.10. CANDELA MEDICAL CORPORATION
7.10.1. OVERVIEW
7.10.2. PRODUCT PORTFOLIO
7.10.3. KEY STRENGTHS
7.10.4. KEY CHALLENGES
8. RESEARCH METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE & DELIVERABLES
8.1.1. OBJECTIVES OF STUDY
8.1.2. SCOPE OF STUDY
8.2. SOURCES OF DATA
8.2.1. PRIMARY DATA SOURCES
8.2.2. SECONDARY DATA SOURCES
8.3. RESEARCH METHODOLOGY
8.3.1. EVALUATION OF THE PROPOSED MARKET
8.3.2. IDENTIFICATION OF DATA SOURCES
8.3.3. ASSESSMENT OF MARKET DETERMINANTS
8.3.4. DATA COLLECTION
8.3.5. DATA VALIDATION & ANALYSIS


TABLE LIST
TABLE 1: NORTH AMERICA CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 2: REGULATORY FRAMEWORK
TABLE 3: LIST OF COLLABORATIONS
TABLE 4: LIST OF PRODUCT LAUNCHES
TABLE 5: LIST OF MERGERS & ACQUISITIONS
TABLE 6: LIST OF BUSINESS DIVESTITURES & EXPANSIONS
TABLE 7: NORTH AMERICA CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2023-2030 (IN $ MILLION)
TABLE 8: NORTH AMERICA CELLULITE TREATMENT MARKET, BY PROCEDURE TYPE, 2023-2030 (IN $ MILLION)
TABLE 9: NORTH AMERICA CELLULITE TREATMENT MARKET, BY END-USER, 2023-2030 (IN $ MILLION)
TABLE 10: NORTH AMERICA CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)

FIGURE LIST
FIGURE 1: MARKET MATURITY ANALYSIS
FIGURE 2: INDUSTRY COMPONENTS
FIGURE 3: KEY BUYING IMPACT ANALYSIS
FIGURE 4: NORTH AMERICA CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2022 & 2030 (IN %)
FIGURE 5: NORTH AMERICA CELLULITE TREATMENT MARKET, BY SOFT CELLULITE, 2023-2030 (IN $ MILLION)
FIGURE 6: NORTH AMERICA CELLULITE TREATMENT MARKET, BY HARD CELLULITE, 2023-2030 (IN $ MILLION)
FIGURE 7: NORTH AMERICA CELLULITE TREATMENT MARKET, BY PROCEDURE TYPE, 2022 & 2030 (IN %)
FIGURE 8: NORTH AMERICA CELLULITE TREATMENT MARKET, BY NON-INVASIVE, 2023-2030 (IN $ MILLION)
FIGURE 9: NORTH AMERICA CELLULITE TREATMENT MARKET, BY MINIMALLY INVASIVE, 2023-2030 (IN $ MILLION)
FIGURE 10: NORTH AMERICA CELLULITE TREATMENT MARKET, BY TOPICAL, 2023-2030 (IN $ MILLION)
FIGURE 11: NORTH AMERICA CELLULITE TREATMENT MARKET, BY END-USER, 2022 & 2030 (IN %)
FIGURE 12: NORTH AMERICA CELLULITE TREATMENT MARKET, BY HOSPITALS, 2023-2030 (IN $ MILLION)
FIGURE 13: NORTH AMERICA CELLULITE TREATMENT MARKET, BY CLINICS AND BEAUTY CENTERS, 2023-2030 (IN $ MILLION)
FIGURE 14: NORTH AMERICA CELLULITE TREATMENT MARKET, BY OTHER END-USERS, 2023-2030 (IN $ MILLION)
FIGURE 15: NORTH AMERICA CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2022 & 2030 (IN %)
FIGURE 16: UNITED STATES CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE 17: CANADA CELLULITE TREATMENT MARKET 2023-2030 (IN $ MILLION)

ページTOPに戻る



List of Tables/Graphs

TABLE LIST
TABLE 1: NORTH AMERICA CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)
TABLE 2: REGULATORY FRAMEWORK
TABLE 3: LIST OF COLLABORATIONS
TABLE 4: LIST OF PRODUCT LAUNCHES
TABLE 5: LIST OF MERGERS & ACQUISITIONS
TABLE 6: LIST OF BUSINESS DIVESTITURES & EXPANSIONS
TABLE 7: NORTH AMERICA CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2023-2030 (IN $ MILLION)
TABLE 8: NORTH AMERICA CELLULITE TREATMENT MARKET, BY PROCEDURE TYPE, 2023-2030 (IN $ MILLION)
TABLE 9: NORTH AMERICA CELLULITE TREATMENT MARKET, BY END-USER, 2023-2030 (IN $ MILLION)
TABLE 10: NORTH AMERICA CELLULITE TREATMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030 (IN $ MILLION)

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

Triton Market Research社の分野での最新刊レポート

  • 最新刊レポートはありません。

本レポートと同じKEY WORD（）の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


Triton Market Research社はどのような調査会社ですか?


Triton Market Researchはヘルスケア、オートメーション、ICT技術、農産業、建設など幅広い産業を対象にした調査およびレポート出版を行っています。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/11/22　10:26

155.52 円

163.34 円

198.56 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.